ACP-204

N/A

Report date: 2026/04/23 20:00:25
NME

Base Information

Drug NameACP-204
Drug Alias NameACP-204
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor inverse agonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsNeuropsychiatryDelusionsHallucinations +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[12
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAcadia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuropsychiatryDelusionsHallucinations +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A